{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:49:00Z","timestamp":1791118140574,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","award":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""],"award-info":[{"award-number":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""]}],"id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","award":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""],"award-info":[{"award-number":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""]}],"id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","award":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""],"award-info":[{"award-number":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""]}],"id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","award":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""],"award-info":[{"award-number":["Clinical Research Priority Program \"Artificial Intelligence in Oncological Imaging\""]}],"id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS 5645-08-2022"],"award-info":[{"award-number":["KFS 5645-08-2022"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS 5645-08-2022"],"award-info":[{"award-number":["KFS 5645-08-2022"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS 5645-08-2022"],"award-info":[{"award-number":["KFS 5645-08-2022"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS 5645-08-2022"],"award-info":[{"award-number":["KFS 5645-08-2022"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Current guidelines for elective nodal irradiation in oropharyngeal squamous cell carcinoma (OPSCC) recommend including large portions of the contralateral lymphatic system in the clinical target volume (CTV-N), even for lateralized tumors with no clinical lymph node involvement in the contralateral neck. This study introduces a probabilistic model of bilateral lymphatic tumor progression in OPSCC to estimate personalized risks of occult disease in specific lymph node levels (LNLs) based on clinical lymph node involvement, T-stage, and tumor lateralization. Building on a previously developed hidden Markov model for ipsilateral lymphatic spread, we extend the approach to contralateral neck involvement. The model represents LNLs I, II, III, IV, V, and VII on both sides of the neck as binary hidden variables (healthy or involved), connected via arcs representing spread probabilities. These probabilities are learned using Markov chain Monte Carlo (MCMC) sampling from a dataset of 833 OPSCC patients, enabling the model to reflect the underlying lymphatic progression dynamics. The model accurately and precisely describes observed patterns of lymph node involvement with a compact set of interpretable parameters. Midline extension of the primary tumor is identified as the primary risk factor for contralateral involvement, with advanced T-stage and extensive ipsilateral involvement further increasing risk. Occult disease in contralateral LNL III is highly unlikely if upstream LNL II is clinically negative, and in contralateral LNL IV, occult disease is exceedingly rare without LNL III involvement. This model offers an interpretable, probabilistic framework to inform personalized elective CTV-N volume reduction. For lateralized tumors that do not cross the midline, it suggests the contralateral neck may safely be excluded from elective irradiation. For tumors extending across the midline but with a clinically negative contralateral neck, elective irradiation could be limited to LNL II, reducing unnecessary exposure of normal tissue while maintaining regional tumor control.<\/jats:p>","DOI":"10.1038\/s41598-025-99978-7","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T05:36:09Z","timestamp":1748151369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A probabilistic model of bilateral lymphatic spread in head and neck cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Roman","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"P\u00e9rez Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Unkelbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"3","key":"99978_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","volume":"69","author":"V Gr\u00e9goire","year":"2003","unstructured":"Gr\u00e9goire, V. et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother. Oncol. 69(3), 227\u2013236. https:\/\/doi.org\/10.1016\/j.radonc.2003.09.011 (2003).","journal-title":"Radiother. Oncol."},{"issue":"1","key":"99978_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","volume":"110","author":"V Gr\u00e9goire","year":"2014","unstructured":"Gr\u00e9goire, V. et al. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother. Oncol. 110(1), 172\u2013181. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.010 (2014).","journal-title":"Radiother. Oncol."},{"issue":"1","key":"99978_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"V Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire, V. et al. Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother. Oncol. 126(1), 3\u201324. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.016 (2018).","journal-title":"Radiother. Oncol."},{"issue":"3","key":"99978_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/srao.2002.32435","volume":"12","author":"A Eisbruch","year":"2002","unstructured":"Eisbruch, A., Foote, R. L., O\u2019Sullivan, B., Beitler, J. J. & Vikram, B. Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin. Radiat. Oncol. 12(3), 238\u2013249. https:\/\/doi.org\/10.1053\/srao.2002.32435 (2002).","journal-title":"Semin. Radiat. Oncol."},{"key":"99978_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","volume":"134","author":"J Biau","year":"2019","unstructured":"Biau, J. et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: A 2019 Update. Radiother. Oncol. 134, 1\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2019.01.018 (2019).","journal-title":"Radiother. Oncol."},{"issue":"5","key":"99978_CR6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0360-3016(02)02881-X","volume":"53","author":"KSC Chao","year":"2002","unstructured":"Chao, K. S. C., Wippold, F. J., Ozyigit, G., Tran, B. N. & Dempsey, J. F. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int. J. Radiat. Oncol. Biol. Phys. 53(5), 1174\u20131184. https:\/\/doi.org\/10.1016\/S0360-3016(02)02881-X (2002).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"99978_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1748-717X-6-97","volume":"6","author":"H Vorwerk","year":"2011","unstructured":"Vorwerk, H. & Hess, C. F. Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: Head and neck region. Radiat. Oncol. 6(1), 97. https:\/\/doi.org\/10.1186\/1748-717X-6-97 (2011).","journal-title":"Radiat. Oncol."},{"issue":"1","key":"99978_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bjoms.2008.06.001","volume":"47","author":"A Ferlito","year":"2009","unstructured":"Ferlito, A., Silver, C. E. & Rinaldo, A. Elective management of the neck in oral cavity squamous carcinoma: Current concepts supported by prospective studies. Br. J. Oral Maxillofac. Surg. 47(1), 5\u20139. https:\/\/doi.org\/10.1016\/j.bjoms.2008.06.001 (2009).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"99978_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2016.08.017","volume":"107","author":"F De Felice","year":"2016","unstructured":"De Felice, F., Musio, D. & Tombolini, V. Osteoradionecrosis and intensity modulated radiation therapy: An overview. Crit. Rev. Oncol. Hematol. 107, 39\u201343. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.08.017 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"99978_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110689","volume":"203","author":"A Koch","year":"2025","unstructured":"Koch, A., Reinhardt, P., Elicin, O., Aebersold, D. M. & Schanne, D. H. Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review. Radiother. Oncol. 203, 110689. https:\/\/doi.org\/10.1016\/j.radonc.2024.110689 (2025).","journal-title":"Radiother. Oncol."},{"issue":"1","key":"99978_CR11","doi-asserted-by":"publisher","first-page":"12261","DOI":"10.1038\/s41598-021-91544-1","volume":"11","author":"R Ludwig","year":"2021","unstructured":"Ludwig, R., Pouymayou, B., Balermpas, P. & Unkelbach, J. A hidden Markov model for lymphatic tumor progression in the head and neck. Sci. Rep. 11(1), 12261. https:\/\/doi.org\/10.1038\/s41598-021-91544-1 (2021).","journal-title":"Sci. Rep."},{"key":"99978_CR12","doi-asserted-by":"publisher","unstructured":"Ludwig, R., Schubert, A., Barbatei, D., Bauwens, L., Hoffmann, J.-M., Werlen, S., Elicin, O., Dettmer, M., Zrounba, P., Pouymayou, B., Balermpas, P., Gr\u00e9goire, V., Giger, R., & Unkelbach, J. Modelling the lymphatic metastatic progression pathways of OPSCC from multi-institutional datasets. arXiv (2023). https:\/\/doi.org\/10.48550\/arXiv.2312.11270","DOI":"10.48550\/arXiv.2312.11270"},{"issue":"16","key":"99978_CR13","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab2a18","volume":"64","author":"B Pouymayou","year":"2019","unstructured":"Pouymayou, B., Balermpas, P., Riesterer, O., Guckenberger, M. & Unkelbach, J. A Bayesian network model of lymphatic tumor progression for personalized elective CTV definition in head and neck cancers. Phys. Med. Biol. 64(16), 165003. https:\/\/doi.org\/10.1088\/1361-6560\/ab2a18 (2019).","journal-title":"Phys. Med. Biol."},{"key":"99978_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2022.108345","volume":"43","author":"R Ludwig","year":"2022","unstructured":"Ludwig, R. et al. A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma. Data Brief 43, 108345. https:\/\/doi.org\/10.1016\/j.dib.2022.108345 (2022).","journal-title":"Data Brief"},{"key":"99978_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2023.110020","volume":"52","author":"R Ludwig","year":"2024","unstructured":"Ludwig, R. et al. A multi-centric dataset on patient-individual pathological lymph node involvement in head and neck squamous cell carcinoma. Data Brief 52, 110020. https:\/\/doi.org\/10.1016\/j.dib.2023.110020 (2024).","journal-title":"Data Brief"},{"issue":"2","key":"99978_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejrad.2007.02.037","volume":"64","author":"RBJ De Bondt","year":"2007","unstructured":"De Bondt, R. B. J. et al. Detection of lymph node metastases in head and neck cancer: A meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur. J. Radiol. 64(2), 266\u2013272. https:\/\/doi.org\/10.1016\/j.ejrad.2007.02.037 (2007).","journal-title":"Eur. J. Radiol."},{"issue":"10","key":"99978_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/jnci\/djn125","volume":"100","author":"PA Kyzas","year":"2008","unstructured":"Kyzas, P. A., Evangelou, E., Denaxa-Kyza, D. & Ioannidis, J. P. A. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: A meta-analysis. JNCI J. Natl. Cancer Inst. 100(10), 712\u2013720. https:\/\/doi.org\/10.1093\/jnci\/djn125 (2008).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"1","key":"99978_CR18","doi-asserted-by":"publisher","first-page":"15750","DOI":"10.1038\/s41598-024-66012-1","volume":"14","author":"R Ludwig","year":"2024","unstructured":"Ludwig, R. et al. Modelling the lymphatic metastatic progression pathways of OPSCC from multi-institutional datasets. Sci. Rep. 14(1), 15750. https:\/\/doi.org\/10.1038\/s41598-024-66012-1 (2024).","journal-title":"Sci. Rep."},{"issue":"925","key":"99978_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1086\/670067","volume":"125","author":"D Foreman-Mackey","year":"2013","unstructured":"Foreman-Mackey, D., Hogg, D. W., Lang, D. & Goodman, J. Emcee: the MCMC hammer. Publ. Astron. Soc. Pac. 125(925), 306\u2013312. https:\/\/doi.org\/10.1086\/670067 (2013).","journal-title":"Publ. Astron. Soc. Pac."},{"issue":"4","key":"99978_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11222-008-9104-9","volume":"18","author":"CJF Ter Braak","year":"2008","unstructured":"Ter Braak, C. J. F. & Vrugt, J. A. Differential evolution Markov chain with snooker updater and fewer chains. Stat. Comput. 18(4), 435\u2013446. https:\/\/doi.org\/10.1007\/s11222-008-9104-9 (2008).","journal-title":"Stat. Comput."},{"issue":"1","key":"99978_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1088\/0067-0049\/210\/1\/11","volume":"210","author":"B Nelson","year":"2013","unstructured":"Nelson, B., Ford, E. B. & Payne, M. J. RUN DMC: An efficient, parallel code for analyzing radial velocity observations using n-body integrations and differential evolution Markov chain Monte Carlo. Astrophys. J. Suppl. Ser. 210(1), 11. https:\/\/doi.org\/10.1088\/0067-0049\/210\/1\/11 (2013).","journal-title":"Astrophys. J. Suppl. Ser."},{"key":"99978_CR22","unstructured":"Benson, N., Whipple, M., & Kalet, I.J. A Markov model approach to predicting regional tumor spread in the lymphatic system of the head and neck. AMIA ... Annual Symposium proceedings. AMIA Symposium, pp. 31\u201335 (2006)"},{"key":"99978_CR23","first-page":"1832","volume":"2016","author":"H Jung","year":"2017","unstructured":"Jung, H. et al. Development of a Novel Markov chain model for the prediction of head and neck squamous cell carcinoma dissemination. AMIA Ann. Symp. Proc. 2016, 1832\u20131839 (2017).","journal-title":"AMIA Ann. Symp. Proc."},{"key":"99978_CR24","unstructured":"University of Zurich: Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck. Clinical Trial Registration NCT06563362, clinicaltrials.gov (2024)"},{"key":"99978_CR25","unstructured":"Sarrut, D., & Rit, S. Proceedings of the XX-th international conference on the use of computers in radiation therapy (ICCR), Lyon, France (2024)"},{"key":"99978_CR26","doi-asserted-by":"publisher","unstructured":"Ludwig, R. Modelling lymphatic metastatic progression in head and neck cancer. PhD thesis, University of Zurich (2023). https:\/\/doi.org\/10.5167\/uzh-231470","DOI":"10.5167\/uzh-231470"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99978-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99978-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99978-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T05:36:11Z","timestamp":1748151371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99978-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99978"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99978-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18152"}}